Citation: Ha. Pollack, Ignoring 'downstream infection' in the evaluation of harm reduction interventions for injection drug users, EUR J EPID, 17(4), 2001, pp. 391-395
Citation: Ha. Pollack, Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users, MED DECIS M, 21(5), 2001, pp. 357-367
Citation: Ha. Pollack, Sudden infant death syndrome, maternal smoking during pregnancy, and the cost-effectiveness of smoking cessation intervention, AM J PUB HE, 91(3), 2001, pp. 432-436
Citation: Ha. Pollack et al., Maternal smoking cessation intervention: Targeting women and their partners before pregnancy - Response, AM J PUB HE, 91(11), 2001, pp. 1734-1734
Citation: Ha. Pollack et Jg. Frohna, A competing risk model of sudden infant death syndrome incidence in two USbirth cohorts, J PEDIAT, 138(5), 2001, pp. 661-667
Authors:
Lantz, PM
Jacobson, PD
Warner, KE
Wasserman, J
Pollack, HA
Person, J
Ahlstrom, A
Citation: Pm. Lantz et al., Investing in youth tobacco control: a review of smoking prevention and control strategies, TOB CONTROL, 9(1), 2000, pp. 47-63